Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Development Center for Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014045
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and development, and training programs to workforce. It offers preclinical development services in the areas of medicinal chemistry and lead optimization to pharmacology and safety studies. DCB provides testing facility for biological safety, CGMP bio-pharmaceutical pilot plant facilities, research technology and industrial promotion services. The organization operates through government, research institutes, academic institutions, and life science industry. It operates through its two offices in Taipei, Taiwan. DCB is headquartered in New Taipei City, Taiwan.

Development Center for Biotechnology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Development Center for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Development Center for Biotechnology, Medical Devices Deals, 2011 to YTD 2017 9
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
DCB Enters Into Licensing Agreement With JoBen Bio-Medical To Develop Anti-Cancer Drugs 12
DCB Enters Into Licensing Agreement With Standard Chem. & Pharm. 13
DCB Enters Into Licensing Agreement With Yung Shin Pharma 14
DCB Enters Into Licensing Agreement With China Chemical & Pharma 15
DCB Enters Into Licensing Agreement With Synmosa Biopharma 16
Asset Transactions 17
EirGenix Acquires Biopharmaceutical Pilot Production Facility From Development Center For Biotechnology 17
QPS Holdings Acquires Center Of Toxicology And Preclinical Sciences From Development Center For Biotech 18
Development Center for Biotechnology – Key Competitors 19
Development Center for Biotechnology – Key Employees 20
Development Center for Biotechnology – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Key Facts 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Development Center for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Development Center for Biotechnology, Deals By Therapy Area, 2011 to YTD 2017 8
Development Center for Biotechnology, Medical Devices Deals, 2011 to YTD 2017 9
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
DCB Enters Into Licensing Agreement With JoBen Bio-Medical To Develop Anti-Cancer Drugs 12
DCB Enters Into Licensing Agreement With Standard Chem. & Pharm. 13
DCB Enters Into Licensing Agreement With Yung Shin Pharma 14
DCB Enters Into Licensing Agreement With China Chemical & Pharma 15
DCB Enters Into Licensing Agreement With Synmosa Biopharma 16
EirGenix Acquires Biopharmaceutical Pilot Production Facility From Development Center For Biotechnology 17
QPS Holdings Acquires Center Of Toxicology And Preclinical Sciences From Development Center For Biotech 18
Development Center for Biotechnology, Key Competitors 19
Development Center for Biotechnology, Key Employees 20
Development Center for Biotechnology, Other Locations 21

★海外企業調査レポート[Development Center for Biotechnology-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Surgical Care Affiliates LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Polyplus-Transfection SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops RNA interference such as STICKY SIRNA and SIRNAPLUS for in vivo research. It …
  • J.Jill Inc (JILL):企業の財務・戦略的SWOT分析
    J.Jill Inc (JILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • The Royal Bank Of Scotland Group Plc:企業の戦略・SWOT・財務分析
    The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Yanzhou Coal Mining Co Ltd:企業のM&A・事業提携・投資動向
    Yanzhou Coal Mining Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yanzhou Coal Mining Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Asian Paints Ltd (ASIANPAINT):企業の財務・戦略的SWOT分析
    Asian Paints Ltd (ASIANPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Whiting Petroleum Corp (WLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Whiting Petroleum Corp (Whiting Petroleum) is an independent oil and gas company that develops, produces, acquires and explores crude oil, natural gas and natural gas liquids (NGL) in the Rocky Mountains region of the US. The company has oil and gas properties in Northern Rocky Mountains whi …
  • Credit Agricole CIB SA:企業の戦略的SWOT分析
    Credit Agricole CIB SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • KAZ Minerals PLC:企業のM&A・事業提携・投資動向
    KAZ Minerals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KAZ Minerals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Hoteli Makarska d.d.:企業の戦略・SWOT・財務情報
    Hoteli Makarska d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Makarska d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Vesuvius Plc:企業の戦略・SWOT・財務情報
    Vesuvius Plc - Strategy, SWOT and Corporate Finance Report Summary Vesuvius Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Gunvor Group Ltd:企業の戦略的SWOT分析
    Gunvor Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析
    U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Muscatine Power and Water:発電所・企業SWOT分析
    Muscatine Power and Water - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆